Galileo Biosystems, Inc. is a preclinical stage company developing a portfolio of novel and mechanistically differentiated aryl hydrocarbon receptor (AhR) small molecule modulators for the treatment of autoimmune and inflammatory diseases.
LifeSci
Galileo Biosystems
OTHER COMPANIES
